Insider Transactions in Q4 2024 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,536
-4.9%
|
$73,608
$3.35 P/Share
|
|
Dec 31
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,697
-3.15%
|
$14,091
$3.35 P/Share
|
|
Dec 31
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,857
-3.64%
|
$14,571
$3.35 P/Share
|
|
Dec 31
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,675
-3.55%
|
$14,025
$3.35 P/Share
|
|
Nov 30
2024
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,901
+0.77%
|
$7,802
$2.1 P/Share
|